Viemed expects to hit the TSX
By HME News Staff
Updated Fri May 11, 2018
LAFAYETTE, La. - Viemed Healthcare has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange to the TSX. Final approval of the listing is subject to the company meeting certain standard and customary conditions required by the TSX by Aug. 2. Viemed expects to satisfy all requirements. “We are pleased to continue the evolution of the Viemed stand-alone entity and feel that the graduation to the TSX is an important step in that process,” said Casey Hoyt, CEO at Viemed. “As our company grows we feel that it is important to position ourselves to attract as many investors as possible, and the TSX listing should open up the doors to a brand new conversation with funds whom had prior restrictions.”
Comments